Replies to post #96385 on $heff's $tation of $tocks & $olid DD

[RKInvHub]

EYEG trading 65%+ higher on expanded partnership agreement with Valeant for EGP-437 in post-operative pain indication.
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
Could be a good sign for potential successful outcome out of the upcoming trial results in uveitis.

Sold 1/3rd @2.36 (from 1.69). Planning to sell another 1/3rd off @2.9x